HAL Allergy Group

rdf:langString HAL Allergy Group

rdf:langString HAL Allergy

rdf:langString HAL Allergy

rdf:langString Dr. Johan Kuijper

rdf:langString Droege International Group

rdf:langString PURETHAL, SUBLIVAC, VENOMENHAL, Provo Test

rdf:langString HAL Allergy Group is a pharmaceutical company that develops, produces and sells products for allergy diagnostic and allergen immunotherapy (AIT). The research facilities and headquarters are located at the Leiden Bio Science Park, Netherlands. The focus since 1959 stems from the development, production and distribution of allergen immunotherapies for the treatment and prevention of allergic diseases. These immunotherapies produced are subcutaneous (SCIT) or sublingual (SLIT) administrated and used primarily against common allergies such as hay fever, house dust mite allergy and allergic reactions towards wasp or bee stings. With offices in major European countries, HAL Allergy is one of the European top players, particularly in the field of allergy. In addition, HAL Allergy has a specific expertise in the area of contract manufacturing with focus on the production of biopharmaceutical products for preclinical and clinical studies. This is done by its subsidiary HALIX B.V. HAL Allergy originally stems from 'Haarlems Allergenen Laboratorium', a Dutch company set up in Haarlem. The company started as a small laboratory where, on request of several local general practitioners (GPs), extracts were prepared on a named patient basis to treat against allergic reactions.